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Progressive Symmetric Erythrokeratoderma
Sevasti Margetas, D.O., Stephen Purcell, D.O.
Lehigh Valley Health Network, Allentown, Pennsylvania

Case Presentation:
• Patient: S.D. is a 17 year-old Caucasian
female.

Figure 1

• History of Present Illness: Patient
presented to our office in 2002. The parents
noted dry skin on the patient’s arms and legs
since a month after birth.  Patient was not a
collodion baby.  Patient has noted progression of
her dry skin over time and flaring in the spring.
• Family History: Paternal grandmother with
similar skin findings.
• Previous treatments: Salicylic acid
lotion, ammonium lactate lotion, urea cream

Figure 2

Figure 3

Figure 4
(H&E- 10X)

• Current treatment: Hydrocortisone/NaCl/
salicylic acid/eucerin compound
• Physical Examination: Pink to orange,
polycyclic, keratotic plaques with slight scale on
the dorsal feet, anterior legs, dorsal hands and
extensor forearms.  The face, trunk and buttocks
are clear.  There is also no involvement of the
palms and soles. (Figures 1, 2 and 3)
• Studies: Loricrin gene test:  pending
• Biopsy: CBL Path (D09NY1-0215286,
6/18/09) Left ankle: “ Sections show skin
with hyperkeratosis consisting of orthoand parakeratosis, underlying acanthosis of
the epidermis with some hypergranulosis,
spongiosis, rare dyskeratotic keratinocytes,
and an underlying superficial dermal mild
perivascular lymphocytic inflammatory infiltrate.”
(Figure 4)

Discussion:
Progressive symmetric erythrokeratoderma (PSEK) was originally
described by Darier in 1911.  It is a very rare disorder of cornification
with increased epidermal cell proliferation.  It is a genetically
heterogenous trait, but mostly autosomal dominant.  Up to 40% of
cases occur sporadically and it can also be autosomal recessive.  
Ishida-Yamamoto et al. detected a frameshift mutation in the
loricrin gene on chromosome 1q in a Japanese family.  Cui et
al. excluded the loricrin gene as the responsible gene in a fivegeneration Chinese family.  This family demonstrated a mutation on
chromosome 21q11.2-q21.2, in an undetermined gene.   Males and
females are equally affected and only the skin is involved.
This disorder typically presents during infancy or early childhood
with fixed, sharply demarcated, polycyclic, hyperkeratotic plaques
on an erythematous base covered by a fine scale or with a rough,
verrucous surface.  The plaques are symmetric and involve the
extensor surface of the extremities, buttocks and face.  Typically, the
trunk is spared.  In most cases, the plaques are slowly progressive,
increasing in number and size over time.  They tend to stabilize after
puberty and sometimes spontaneously resolve.  Approximately 50%
of patients may also have erythematous palmoplantar keratoderma.
Diagnosis of PSEK can be difficult due to the shared clinical and
histopathological features with erythrokeratoderma variabilis
(EKV). (Table 1) Clinically, in PSEK, the erythema underlies the fixed
hyperkeratotic plaques, as opposed to the erythematous patches
in EKV, which vary in size and location over minutes to days.  
However, palmoplantar keratoderma is more common in PSEK than
EKV. Involvement of the thorax and abdomen is more common in
EKV than PSEK.  Both entities share non-specific histopathologic
features including, basket-weave stratum corneum, hyperkeratosis
with focal parakeratosis, follicular plugging, acanthosis of the
epidermis, a prominent granular layer that may contain large
polygonal clumps of keratohyaline and a sparse to moderate
perivascular lymphocytic infiltrate.  Electron microscopy and genetic
testing can be used to definitively differentiate these entities.

Table 1

Location
Erythematous Patches
Palmoplantar
Keratoderma
Histopathology
Electron Microscopy

Genetics

PSEK

EKV

Spares trunk

Thorax and abdomen

Stable; underlying hyperkeratotic
plaques

Variable size and location;
minutes to days

50% of patients

Less common

Similar non-specific findings

Similar non-specific findings

• Stratum corneum: lipid vacuoles
• Swollen mitochondria coalescing
in perinuclear location

• Papillary dermis:
      ↑ unmyelinated nerve fibers
• Granular layer:
      ↑ keratinosomes

Loricrin gene: chromosome 1q
Unknown gene: chromosome 21q

Connexin genes GJB3-4:
chromosome 1p34-35.1

Treatment can also be difficult for patients with persistent disease.  
Topical agents, which have proven to be minimally effective, include
urea, α-hydroxy acids, propylene glycol, salicylic acid, coal tar and
retinoids.  Calcipotriol cream has also been used with unknown
effectiveness.  Systemically, isotretinoin, acitretin, etretinate therapy
and oral psoralen-UV-A have been shown to be effective.
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